Ilya Tsimafeyeu, MD (he/him/his)

Director
Bureau for Cancer Research

Director, Bureau for Cancer Research, New York, NY
Member, International Education Steering Group, ASCO
Faculty Member, College of the European School of Oncology (ESCO)

Poster(s):

• 41: Efficacy of nivolumab plus ipilimumab in T1aN0M0 renal cell carcinoma patients ineligible for surgery and ablation